HPV16-E7 Expression Causes Fluorodeoxyuridine-mediated Radiosensitization in SW620 Human Colon Cancer Cells

by Michael D. Axelson, Mary A. Davis, Stephen P. Ethier, Theodore S. Lawrence
Published 1999-06-01

Inducing Oncoprotein Degradation to Improve Targeted Cancer Therapy

by Dipankar Ray, Kyle C. Cuneo, Alnawaz Rehemtulla, Theodore S. Lawrence, Mukesh K. Nyati
Published 2015-09-01

SAK, A New Polo-Like Kinase, Is Transcriptionally Repressed by p53 and Induces Apoptosis upon RNAi Silencing

by Jun Li, Mingjia Tan, Ling Li, Deepika Pamarthy, Theodore S. Lawrence, Yi Sun
Published 2005-04-01

Enhancing the Radiation Response in KRAS Mutant Colorectal Cancers Using the c-Met Inhibitor Crizotinib

by Kyle C. Cuneo, Ranjit K. Mehta, Himabindu Kurapati, Dafydd G. Thomas, Theodore S. Lawrence, Mukesh K. Nyati
Published 2019-02-01

Natural proteasome inhibitor celastrol suppresses androgen-independent prostate cancer progression by modulating apoptotic proteins and NF-kappaB.

by Yao Dai, Jeffrey Desano, Wenhua Tang, Xiaojie Meng, Yang Meng, Ezra Burstein, Theodore S Lawrence, Liang Xu
Published 2010-12-01

Low Dose Rate Radiosensitization of Hepatocellular Carcinoma In Vitro and in Patients

by Kyle C. Cuneo, Mary A. Davis, Mary U. Feng, Paula M. Novelli, William D. Ensminger, Theodore S. Lawrence
Published 2014-08-01

Disruptin, a cell-penetrating peptide degrader of EGFR

by Ranjit K. Mehta, Sushmita Shukla, Susmita G. Ramanand, Vishal Somnay, Alexander J. Bridges, Theodore S. Lawrence, Mukesh K. Nyati
Published 2021-08-01

Regional variation in brain white matter diffusion index changes following chemoradiotherapy: a prospective study using tract-based spatial statistics.

by Christopher H Chapman, Mohammad Nazem-Zadeh, Oliver E Lee, Matthew J Schipper, Christina I Tsien, Theodore S Lawrence, Yue Cao
Published 2013-01-01

Survival Prediction Analysis in Glioblastoma With Diffusion Kurtosis Imaging

by Yuan Li, Yuan Li, Michelle M. Kim, Daniel R. Wahl, Theodore S. Lawrence, Hemant Parmar, Yue Cao, Yue Cao, Yue Cao
Published 2021-07-01

Development and validation of a novel platform-independent metastasis signature in human breast cancer.

by Shuang G Zhao, Mark Shilkrut, Corey Speers, Meilan Liu, Kari Wilder-Romans, Theodore S Lawrence, Lori J Pierce, Felix Y Feng
Published 2015-01-01

Fbxw7 Deletion Accelerates KrasG12D-Driven Pancreatic Tumorigenesis via Yap Accumulation

by Qiang Zhang, Yaqing Zhang, Joshua D. Parsels, Ines Lohse, Theodore S. Lawrence, Marina Pasca di Magliano, Yi Sun, Meredith A. Morgan
Published 2016-11-01

Phase I Trial of Radiotherapy Concurrent with Twice-Weekly Gemcitabine for Head and Neck Cancer: Translation From Preclinical Investigations Aiming to Improve the Therapeutic Ratio

by Aron Popovtzer, Daniel Normolle, Francis P. Worden, Mark E. Prince, Douglas B. Chepeha, Gregory T. Wolf, Carol R. Bradford, Theodore S. Lawrence, Avraham Eisbruch
Published 2014-08-01

Sensitization of Pancreatic Cancers to Gemcitabine Chemoradiation by WEE1 Kinase Inhibition Depends on Homologous Recombination Repair

by Tasneem Kausar, Jason S. Schreiber, David Karnak, Leslie A. Parsels, Joshua D. Parsels, Mary A. Davis, Lili Zhao, Jonathan Maybaum, Theodore S. Lawrence, Meredith A. Morgan
Published 2015-10-01

Targeting Mcl-1 for Radiosensitization of Pancreatic Cancers

by Dongping Wei, Qiang Zhang, Jason S. Schreiber, Leslie A. Parsels, Fardokht A. Abulwerdi, Tasneem Kausar, Theodore S. Lawrence, Yi Sun, Zaneta Nikolovska-Coleska, Meredith A. Morgan
Published 2015-02-01

Targeted Radiosensitization of ETS Fusion-Positive Prostate Cancer through PARP1 Inhibition

by Sumin Han, J Chad Brenner, Aaron Sabolch, Will Jackson, Corey Speers, Kari Wilder-Romans, Karen E Knudsen, Theodore S Lawrence, Arul M Chinnaiyan, Felix Y Feng
Published 2013-10-01

Sensitization of Pancreatic Cancer Stem Cells to Gemcitabine by Chk1 Inhibition

by Venkatasubbaiah A. Venkatesha, Leslie A. Parsels, Joshua D. Parsels, Lili Zhao, Sonya D. Zabludoff, Diane M. Simeone, Jonathan Maybaum, Theodore S. Lawrence, Meredith A. Morgan
Published 2012-06-01

Efficacy of an EGFR-Specific Peptide against EGFR-Dependent Cancer Cell Lines and Tumor Xenografts

by Aarif Ahsan, Susmita G. Ramanand, Ingrid L. Bergin, Lilli Zhao, Christopher E. Whitehead, Alnawaz Rehemtulla, Dipankar Ray, William B. Pratt, Theodore S. Lawrence, Mukesh K. Nyati
Published 2014-02-01

Regulation of EGFR Protein Stability by the HECT-type Ubiquitin Ligase SMURF2

by Dipankar Ray, Aarif Ahsan, Abigail Helman, Guoan Chen, Ashok Hegde, Susmita Ramanand Gurjar, Lili Zhao, Hiroaki Kiyokawa, David G Beer, Theodore S Lawrence, Mukesh K Nyati
Published 2011-07-01

MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells.

by Qing Ji, Xinbao Hao, Min Zhang, Wenhua Tang, Meng Yang, Ling Li, Debing Xiang, Jeffrey T Desano, Guido T Bommer, Daiming Fan, Eric R Fearon, Theodore S Lawrence, Liang Xu
Published 2009-08-01

Expansion of Circulating Tumor Cells from Patients with Locally Advanced Pancreatic Cancer Enable Patient Derived Xenografts and Functional Studies for Personalized Medicine

by Lianette Rivera-Báez, Ines Lohse, Eric Lin, Shreya Raghavan, Sarah Owen, Ramdane Harouaka, Kirk Herman, Geeta Mehta, Theodore S. Lawrence, Meredith A. Morgan, Kyle C. Cuneo, Sunitha Nagrath
Published 2020-04-01